Interbody device footprint and endplate engagement characteristics: biomechanical implications

Received 13 April 2009; accepted 17 April 2009.

COMMENTARY ON: Buttermann GR, Beaubien BP, Freeman AL, et al. Interbody device endplate engagement effects on motion segment biomechanics. Spine J 2009;9:564–573 (this issue).

Cleveland Clinic Foundation, Orthopedic Surgery, S80, 9500 Euclid Avenue, Cleveland, OH 44195, USA

Corresponding author. Cleveland Clinic Foundation, Orthopedic Surgery, S80, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

FDA device/drug status: not applicable.

Author disclosures: ECB (royalties from Depuy Spine; stockholder at OrthoMEMS and AxioMed; private investor at AxioMed; consultant for Turning Ponit, speaker for DePuy; member of scientific advisory board at OrthoMEMS and Turning Point).

PII: S1529-9430(09)00169-7

doi:10.1016/j.spinee.2009.04.013

17 of 24